Pharmaron Beijing Co., Ltd.
3759Biotechnology
HK$26.92−0.07%As of Oct 29vs prior close
- Market cap
- $1.2B
- P/E (TTM)
- 4.6×
- P/E (FY1)
- 19.9×
- From 52W high
- −20.50%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥15.2B
- Net margin
- 11.05%
Nomior Score
62
Steady ProfileTop 23% of the scored universe
Growth68
Quality60
Value56
Momentum61
Resilience43
Growth
+11.14%revenue a year over 3 fiscal years
YE22 CN¥10.3BLTM CN¥15.2B
Connections
Revenue to profitYE25
12% of revenue became net profit, down 3 pts on a year.